{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:28:57Z","timestamp":1788863337348,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>The aim of this study was to evaluate the effects of radiotherapy plus concurrent weekly cisplatin chemotherapy on the postoperative recurrence of mediastinal lymph node metastases in esophageal cancer patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Ninety-eight patients were randomly enrolled to receive either three-dimensional conformal radiotherapy alone (group A) or concurrent chemoradiotherapy (group B). A radiation dose of 62\u201370\u00a0Gy\/31\u201335 fractions was delivered to the recurrent tumor. Furthermore, the patients in group B simultaneously received weekly doses of cisplatin (30\u00a0mg\/m<jats:sup>2<\/jats:sup>), and the survival outcomes and toxic effects were compared.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The response rate of group B (91.8%) was significantly greater than that of group A (73.5%) (<jats:italic>\u03c7<\/jats:italic>\n              <jats:sup>2<\/jats:sup>\u2009=\u20095.765, <jats:italic>P<\/jats:italic>\u2009=\u20090.016). The 1- and 3-year survival rates of group B (85.7% and 46.9%, respectively) were also greater than those of group A (69.4% and 28.6%, respectively). However, there were no significant differences in the 5-year survival rates. The numbers of patients who died of distant metastases in groups A and B were 13 (26.5%) and 5 (10.2%), respectively (<jats:italic>\u03c7<\/jats:italic>\n              <jats:sup>2<\/jats:sup>\u2009=\u20094.356, <jats:italic>P<\/jats:italic>\u2009=\u20090.036). Acute radiation-related esophagitis and granulocytopenia in group B was frequent. However, intergroup differences in terms of late toxicity were not significant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Three-dimensional conformal radiotherapy (3DCRT) is a practical and feasible technique to treat the recurrence of mediastinal lymph node metastases of postoperative esophageal cancer. In addition, concurrent chemotherapy can increase local tumor control, decrease the distant metastasis rate, and increase the long-term survival rate.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1748-717x-9-28","type":"journal-article","created":{"date-parts":[[2014,1,19]],"date-time":"2014-01-19T02:04:00Z","timestamp":1390097040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 single-institution study"],"prefix":"10.1186","volume":"9","author":[{"given":"Dai-yuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-xian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-fu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-qin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,19]]},"reference":[{"key":"1215_CR1","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJMra035010","volume":"349","author":"PC Enzinger","year":"2003","unstructured":"Enzinger PC, Mayer RJ: Esophageal cancer. N Engl J Med 2003, 349: 2241-2252. 10.1056\/NEJMra035010","journal-title":"N Engl J Med"},{"key":"1215_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3322\/caac.21149","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E: Cancer treatment and survivorship statistics. 2012. CA Cancer J Clin 2012, 62: 220-241. 10.3322\/caac.21149","journal-title":"CA Cancer J Clin"},{"key":"1215_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S1470-2045(03)01167-7","volume":"4","author":"PC Wu","year":"2003","unstructured":"Wu PC, Posner MC: The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003, 4: 481-488. 10.1016\/S1470-2045(03)01167-7","journal-title":"Lancet Oncol"},{"key":"1215_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A: Cancer statistics. 2012. CA Cancer J Clin 2012, 62: 10-29. 10.3322\/caac.20138","journal-title":"CA Cancer J Clin"},{"key":"1215_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S1470-2045(05)70347-8","volume":"6","author":"I Rouvelas","year":"2005","unstructured":"Rouvelas I, Zeng W, Lindblad M, Viklund P, Ye W, Lagergren J: Survival after surgery for oesophageal cancer: A population-based study. Lancet Oncol 2005, 6: 864-870. 10.1016\/S1470-2045(05)70347-8","journal-title":"Lancet Oncol"},{"key":"1215_CR6","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ejso.2006.02.014","volume":"32","author":"S Natsugoe","year":"2006","unstructured":"Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Uenosono Y, Ishigami S, Owaki T, Aikou T: The role of salvage surgery for recurrence of esophageal squamous cell cancer. Eur J Surg Oncol 2006, 32: 544-547. 10.1016\/j.ejso.2006.02.014","journal-title":"Eur J Surg Oncol"},{"key":"1215_CR7","first-page":"1616","volume":"97","author":"C Mariette","year":"2003","unstructured":"Mariette C, Balon JM, Piessen G, Fabre S, Van Seuningen I, Triboulet JP: Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer-Am Cancer Soc 2003, 97: 1616-1623.","journal-title":"Cancer-Am Cancer Soc"},{"key":"1215_CR8","first-page":"2393","volume":"46","author":"L Sanz","year":"1999","unstructured":"Sanz L, Gonzalez JJ, Miyar A, Navarrete F, Martinez E: Pattern of recurrence after esophageal resection for cancer. Hepatogastroenterology 1999, 46: 2393-2397.","journal-title":"Hepatogastroenterology"},{"key":"1215_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.amjsurg.2004.06.003","volume":"188","author":"T Nakamura","year":"2004","unstructured":"Nakamura T, Hayashi K, Ota M, Eguchi R, Ide H, Takasaki K, Mitsuhashi N: Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 2004, 188: 261-266. 10.1016\/j.amjsurg.2004.06.003","journal-title":"Am J Surg"},{"key":"1215_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/jso.21353","volume":"100","author":"H Miyata","year":"2009","unstructured":"Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Nishida T, Mori M, Doki Y: Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol 2009, 100: 442-446. 10.1002\/jso.21353","journal-title":"J Surg Oncol"},{"key":"1215_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1748-717X-7-93","volume":"7","author":"J Zhang","year":"2012","unstructured":"Zhang J, Peng F, Li N, Liu Y, Xu Y, Zhou L, Wang J, Zhu J, Huang M, Gong Y: Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer. Radiat Oncol 2012, 7: 93. 10.1186\/1748-717X-7-93","journal-title":"Radiat Oncol"},{"key":"1215_CR12","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.ijrobp.2011.01.043","volume":"82","author":"SG Swisher","year":"2012","unstructured":"Swisher SG, Winter KA, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG: A phase ii study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: Initial reporting of rtog 0246. Int J Radiat Oncol Biol Phys 2012, 82: 1967-1972. 10.1016\/j.ijrobp.2011.01.043","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1215_CR13","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1200\/JCO.2011.36.7599","volume":"29","author":"CM Thallinger","year":"2011","unstructured":"Thallinger CM, Raderer M, Hejna M: Esophageal cancer: A critical evaluation of systemic second-line therapy. J Clin Oncol 2011, 29: 4709-4714. 10.1200\/JCO.2011.36.7599","journal-title":"J Clin Oncol"},{"key":"1215_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.radonc.2009.10.014","volume":"93","author":"KL Wu","year":"2009","unstructured":"Wu KL, Chen GY, Xu ZY, Fu XL, Qian H, Jiang GL: Three-dimensional conformal radiation therapy for squamous cell carcinoma of the esophagus: A prospective phase i\/ii study. Radiother Oncol 2009, 93: 454-457. 10.1016\/j.radonc.2009.10.014","journal-title":"Radiother Oncol"},{"key":"1215_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2407-6-50","volume":"6","author":"K Jingu","year":"2006","unstructured":"Jingu K, Nemoto K, Matsushita H, Takahashi C, Ogawa Y, Sugawara T, Nakata E, Takai Y, Yamada S: Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer. BMC Cancer 2006, 6: 50. 10.1186\/1471-2407-6-50","journal-title":"BMC Cancer"},{"key":"1215_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0167-8140(01)00392-9","volume":"61","author":"K Nemoto","year":"2001","unstructured":"Nemoto K, Ariga H, Kakuto Y, Matsushita H, Takeda K, Takahashi C, Takai Y, Yamada S, Hosoi Y: Radiation therapy for loco-regionally recurrent esophageal cancer after surgery. Radiother Oncol 2001, 61: 165-168. 10.1016\/S0167-8140(01)00392-9","journal-title":"Radiother Oncol"},{"key":"1215_CR17","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/jjco\/hym138","volume":"37","author":"Y Shioyama","year":"2007","unstructured":"Shioyama Y, Nakamura K, Ohga S, Nomoto S, Sasaki T, Yamaguchi T, Toba T, Yoshitake T, Terashima H, Honda H: Radiation therapy for recurrent esophageal cancer after surgery: Clinical results and prognostic factors. Jpn J Clin Oncol 2007, 37: 918-923. 10.1093\/jjco\/hym138","journal-title":"Jpn J Clin Oncol"},{"key":"1215_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1440-1673.2008.02023.x","volume":"52","author":"SH Baxi","year":"2008","unstructured":"Baxi SH, Burmeister B, Harvey JA, Smithers M, Thomas J: Salvage definitive chemo-radiotherapy for locally recurrent oesophageal carcinoma after primary surgery: Retrospective review. J Med Imaging Radiat Oncol 2008, 52: 583-587. 10.1111\/j.1440-1673.2008.02023.x","journal-title":"J Med Imaging Radiat Oncol"},{"key":"1215_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12029-009-9051-5","volume":"39","author":"SJ Amonkar","year":"2008","unstructured":"Amonkar SJ, Irving M, Wayman J, Sriram T, Griffin SM, Nicoll JJ, Raimes SA: The changing use of palliative chemotherapy for recurrent esophagogastric cancer: A single center retrospective 15-year review. J Gastrointest Cancer 2008, 39: 51-57. 10.1007\/s12029-009-9051-5","journal-title":"J Gastrointest Cancer"},{"key":"1215_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijrobp.2004.08.046","volume":"62","author":"ZF Xiao","year":"2005","unstructured":"Xiao ZF, Yang ZY, Miao YJ, Wang LH, Yin WB, Gu XZ, Zhang DC, Sun KL, Chen GY, He J: Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: Report of 549 cases. Int J Radiat Oncol Biol Phys 2005, 62: 82-90. 10.1016\/j.ijrobp.2004.08.046","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1215_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1442-2050.2005.00502.x","volume":"18","author":"H Yamashita","year":"2005","unstructured":"Yamashita H, Nakagawa K, Tago M, Nakamura N, Shiraishi K, Ohtomo K: Salvage radiotherapy for postoperative loco-regional recurrence of esophageal cancer. Dis Esophagus 2005, 18: 215-220. 10.1111\/j.1442-2050.2005.00502.x","journal-title":"Dis Esophagus"},{"key":"1215_CR22","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1259\/bjr\/19972578","volume":"77","author":"VW Wu","year":"2004","unstructured":"Wu VW, Sham JS, Kwong DL: Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer. Br J Radiol 2004, 77: 568-572. 10.1259\/bjr\/19972578","journal-title":"Br J Radiol"},{"key":"1215_CR23","first-page":"48","volume":"6","author":"CX Yang","year":"2005","unstructured":"Yang CX, Wang HY, Wang ZM, Du HZ, Tao DM, Mu XY, Chen HG, Lei Y, Matsuo K, Tajima K: Risk factors for esophageal cancer: A case\u2013control study in south-western china. Asian Pac J Cancer Prev 2005, 6: 48-53.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1215_CR24","volume-title":"Tnm classification of malignant tumors, ed 6th","author":"LH Sobin","year":"2002","unstructured":"Sobin LH, Wittekind CH: Tnm classification of malignant tumors, ed 6th. New York: Wiley-Liss; 2002."},{"key":"1215_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, national cancer institute of the united states, national cancer institute of canada. J Natl Cancer Inst 2000, 92: 205-216. 10.1093\/jnci\/92.3.205","journal-title":"J Natl Cancer Inst"},{"key":"1215_CR26","first-page":"364","volume":"2004","author":"HR Wabinga","year":"2018","unstructured":"Wabinga HR, Colebunders B, Odida M, Ocama P, Colebunders R: Risk factors for and types of oesophageal cancer. Lancet 2018, 2004: 364.","journal-title":"Lancet"},{"key":"1215_CR27","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1200\/JCO.2007.12.0881","volume":"25","author":"L Kleinberg","year":"2007","unstructured":"Kleinberg L, Forastiere AA: Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007, 25: 4110-4117. 10.1200\/JCO.2007.12.0881","journal-title":"J Clin Oncol"},{"key":"1215_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S1470-2045(06)70643-X","volume":"7","author":"E Susman","year":"2006","unstructured":"Susman E: Combined therapy improves survival in oesophageal cancer. Lancet Oncol 2006, 7: 290.","journal-title":"Lancet Oncol"},{"key":"1215_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S1470-2045(07)70172-9","volume":"8","author":"C Mariette","year":"2007","unstructured":"Mariette C, Piessen G, Triboulet JP: Therapeutic strategies in oesophageal carcinoma: Role of surgery and other modalities. Lancet Oncol 2007, 8: 545-553. 10.1016\/S1470-2045(07)70172-9","journal-title":"Lancet Oncol"},{"key":"1215_CR30","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1200\/JCO.20.5.1167","volume":"20","author":"BD Minsky","year":"2002","unstructured":"Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP: Int 0123 (radiation therapy oncology group 94\u201305) phase iii trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 2002, 20: 1167-1174. 10.1200\/JCO.20.5.1167","journal-title":"J Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-9-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:47:06Z","timestamp":1630583226000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-9-28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,19]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1215"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-9-28","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,19]]},"assertion":[{"value":"7 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"28"}}